| Followers | 0 |
| Posts | 1357 |
| Boards Moderated | 0 |
| Alias Born | 03/20/2022 |
Thursday, April 07, 2022 2:03:55 AM
Not sure why you keep trying to debase Revive by classing it with Relief....yeah, the swiss pos you still promote to this day.
The concern about our 320M OS is really hilarious since again, the oinker Relief's OS is like 4B+ and yet you have no issue with that catastrophe.
You and a few others are so transparent, but do keep at it and in so doing entertain us with these lackluster posts.
The concern about our 320M OS is really hilarious since again, the oinker Relief's OS is like 4B+ and yet you have no issue with that catastrophe.
You and a few others are so transparent, but do keep at it and in so doing entertain us with these lackluster posts.
Recent RVVTF News
- Revive Therapeutics Strengthens Bucillamine IP Portfolio with North American Patent Filings for Nerve Agent Exposure and Granted Canadian Patent for Infectious Diseases • ACCESS Newswire • 03/11/2026 11:30:00 AM
- Revive Therapeutics Provides Update of Key Nerve Agent Countermeasure Study • GlobeNewswire Inc. • 12/15/2025 12:30:00 PM
- Revive Therapeutics Provides Update of Key Nerve Agent Countermeasure Study • GlobeNewswire Inc. • 11/21/2025 05:07:49 PM
- Revive Therapeutics Announces Closing of Second Tranche of Private Placement • GlobeNewswire Inc. • 09/19/2025 09:00:28 PM
